Recruitment completed
Trial summary
The purpose of this study is to evaluate the long-term safety of zanubrutinib regimens in participants with B-cell malignancies who participated in a BeiGene parent study for zanubrutinib.
Trial details
Short title
BGB-3111-LTE1
Diagnosis
B-cell malignancies
Type of treatment
Haematology
Phase
III
Locations
Who can participate
Clinical trials can have restrictive criteria of who can and can’t participate, talk to your healthcare provider if you are interested in this clinical trial.